Alan D Sobel Net Worth & Insider Trades
Alan D Sobel - Director, Cytosorbents Corp
What is Alan D Sobel's Net Worth?
The current estimated net worth of Cytosorbents Corp's Director, Alan D Sobel, is estimated to be about $240.47K . Alan D Sobel owns about 81,300 units of Cytosorbents Corp common stock. In the last 8 years at Cytosorbents Corp, Alan D Sobel has sold an estimated value of $0 worth.
What is Alan D Sobel's Past Insider Trading?
Alan D Sobel's largest purchase order was 10,000 units , worth over $20.17K on May 12, 2022. In total, Alan D Sobel has made about 12 transactions over 8 years of their time at Cytosorbents Corp. Alan D Sobel usually trades in April, with the busiest year in 2022.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alan D Sobel
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Alan D Sobel's' Mailing Address?
- Mailing address is 293 Eisenhower Parkway Livingston NJ 07039 NJ
Cytosorbents Corp Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Phillip P. Chan, MD, PhD | 2020 | $455,520 | $260,557 | $361,800 | $298,313 | $12,000 | $1,388,190 |
| Phillip P. Chan, MD, PhD | 2019 | $438,000 | $99,645 | $484,075 | $370,656 | $12,000 | $1,404,376 |
| Phillip P. Chan, MD, PhD | 2018 | $400,000 | $160,000 | $337,550 | $337,745 | $12,000 | $1,247,295 |
| Vincent J. Capponi, MS | 2020 | $400,000 | $197,208 | $326,223 | $253,566 | - | $1,176,997 |
| Vincent J. Capponi, MS | 2019 | $363,540 | $57,258 | $433,744 | $315,058 | - | $1,169,600 |
| Vincent J. Capponi, MS | 2018 | $332,000 | $132,800 | $298,300 | $316,520 | - | $1,079,620 |
| Kathleen P. Bloch, MBA, CPA | 2020 | $349,460 | $138,386 | $259,290 | $223,735 | - | $970,871 |
| Kathleen P. Bloch, MBA, CPA | 2019 | $323,025 | $50,876 | $347,954 | $277,992 | - | $999,847 |
| Kathleen P. Bloch, MBA, CPA | 2018 | $295,000 | $118,000 | $272,395 | $268,188 | - | $953,583 |
| Efthymios N. Deliargyris, MD | 2020 | $253,212 | $101,640 | $131,800 | $331,912 | $8,654 | $827,217 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1175151/000110465921051985/tm2113212-1_def14a.htm
What are Cytosorbents Corp's Past Insider Trades?
Cytosorbents Corp's most recent insider trade came on August 8, 2023 by Michael G Bator who bought 3,000 units worth $9.58K . In the last 12 years, insiders at Cytosorbents Corp have sold an estimated value of $6.87M and bought an estimated value of $5.54M worth of shares. Insider trading is most common in July, with the busiest year in 2014. The most active traders at the company are Al Kraus, Director, Kathleen P Bloch, Chief Financial Officer, and Phillip P Chan, Chief Executive Officer .
Cytosorbents Corp Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||